Point72 Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
Point72 Asset Management's ANGO Position: Q3 2026 in Review
Point72 Asset Management reduced its AngioDynamics (ANGO) stake by 68% in Q3 2026, selling an estimated $31.2M and leaving 964,953 shares worth $14.8M. The position accounts for 0.02% of the portfolio, ranked #1095.
Point72 Asset Management first reported a position in ANGO in Q2 2014 and has held it in 22 quarters since. The position peaked at $39.8M in Q2 2026. 165 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.
- Point72 Asset Management held 964,953 shares of AngioDynamics worth $14.8M as of Q3 2026.
- Point72 Asset Management sold 2,097,564 AngioDynamics shares in Q3 2026, an estimated $31.2M.
- AngioDynamics made up 0.02% of Point72 Asset Management's portfolio in Q3 2026, its #1095 holding.
- Point72 Asset Management first reported a position in AngioDynamics in Q2 2014 and has held it in 22 quarters since.
- Point72 Asset Management's AngioDynamics position peaked at $39.8M in Q2 2026.
- 165 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.